Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Indiana Seed Fund is a family of early-stage venture capital funds managed by BioCrossroads, Indiana's initiative to advance the life sciences sector. The funds provide critical seed-stage capital to promising Indiana-based companies in the biotechnology, pharmaceutical, medical device, and health information technology sectors. By bridging the funding gap for early-stage startups, the Indiana Seed Fund aims to foster innovation and commercialize breakthrough technologies originating from the state's research institutions and entrepreneurial community. Since its inception in 2005, the fund has supported numerous companies that have gone on to achieve significant clinical milestones and successful exits. Notable portfolio companies have included those focused on drug discovery, diagnostics, and digital health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indiana Seed Fund.